Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Inventory (2018 - 2025)

Historic Inventory for Dr Reddys Laboratories (RDY) over the last 9 years, with Q1 2025 value amounting to $820.9 million.

  • Dr Reddys Laboratories' Inventory rose 726.91% to $820.9 million in Q1 2025 from the same period last year, while for Mar 2025 it was $820.9 million, marking a year-over-year increase of 726.91%. This contributed to the annual value of $832.0 million for FY2025, which is 904.33% up from last year.
  • Latest data reveals that Dr Reddys Laboratories reported Inventory of $820.9 million as of Q1 2025, which was up 726.91% from $765.3 million recorded in Q1 2024.
  • In the past 5 years, Dr Reddys Laboratories' Inventory registered a high of $820.9 million during Q1 2025, and its lowest value of $592.1 million during Q1 2023.
  • In the last 5 years, Dr Reddys Laboratories' Inventory had a median value of $676.7 million in 2022 and averaged $695.5 million.
  • Per our database at Business Quant, Dr Reddys Laboratories' Inventory tumbled by 1250.86% in 2023 and then skyrocketed by 2925.38% in 2024.
  • Over the past 5 years, Dr Reddys Laboratories' Inventory (Quarter) stood at $622.8 million in 2021, then increased by 8.65% to $676.7 million in 2022, then dropped by 12.51% to $592.1 million in 2023, then rose by 29.25% to $765.3 million in 2024, then increased by 7.27% to $820.9 million in 2025.
  • Its Inventory was $820.9 million in Q1 2025, compared to $765.3 million in Q1 2024 and $592.1 million in Q1 2023.